CA1096307A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
CA1096307A
CA1096307A CA220,535A CA220535A CA1096307A CA 1096307 A CA1096307 A CA 1096307A CA 220535 A CA220535 A CA 220535A CA 1096307 A CA1096307 A CA 1096307A
Authority
CA
Canada
Prior art keywords
digoxin
preparation
solution
amount
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA220,535A
Other languages
English (en)
French (fr)
Other versions
CA220535S (en
Inventor
Elvin A. Holstius
Ronald M. Cresswell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1096307A publication Critical patent/CA1096307A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA220,535A 1974-02-22 1975-02-21 Pharmaceutical preparations Expired CA1096307A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44496174A 1974-02-22 1974-02-22
US444961 1974-02-22
US45300074A 1974-03-19 1974-03-19
US453000 1974-03-19

Publications (1)

Publication Number Publication Date
CA1096307A true CA1096307A (en) 1981-02-24

Family

ID=27034126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA220,535A Expired CA1096307A (en) 1974-02-22 1975-02-21 Pharmaceutical preparations

Country Status (14)

Country Link
JP (1) JPS50126822A (it)
AU (2) AU501549B2 (it)
CA (1) CA1096307A (it)
DE (1) DE2507635A1 (it)
ES (1) ES434971A1 (it)
FI (1) FI750489A (it)
FR (1) FR2261752B1 (it)
GB (1) GB1506016A (it)
IE (1) IE41620B1 (it)
IL (1) IL46682A (it)
IT (1) IT1233251B (it)
LU (1) LU71894A1 (it)
NL (1) NL7502121A (it)
SE (1) SE426549B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508770A (en) * 1974-04-01 1978-04-26 Scherer Ltd R Pharmaceutical compositions
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
FR2380030A1 (fr) * 1977-02-09 1978-09-08 Christiaens Sa A Composition pharmaceutique contenant de la gitoxine
IT1158722B (it) * 1977-07-08 1987-02-25 Simes Composizione farmaceutica per il trattamento delle turbe del sonno
JPS5625428U (it) * 1979-08-03 1981-03-09
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DE3445237C1 (de) * 1984-12-12 1986-06-05 R.P. Scherer GmbH, 6930 Eberbach Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DE3529694A1 (de) * 1985-08-20 1987-02-26 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions

Also Published As

Publication number Publication date
IE41620L (en) 1975-08-22
IL46682A (en) 1979-07-25
GB1506016A (en) 1978-04-05
DE2507635A1 (de) 1975-08-28
LU71894A1 (it) 1975-12-09
NL7502121A (nl) 1975-08-26
AU520082B2 (en) 1982-01-14
IT8349395A0 (it) 1983-11-28
FR2261752B1 (it) 1978-07-21
AU501549B2 (en) 1979-06-21
AU7844075A (en) 1976-08-26
SE7501967L (it) 1975-08-25
IL46682A0 (en) 1975-04-25
IT1233251B (it) 1992-03-24
JPS50126822A (it) 1975-10-06
DE2507635C2 (it) 1991-07-25
FR2261752A1 (it) 1975-09-19
ES434971A1 (es) 1977-05-16
IE41620B1 (en) 1980-02-13
FI750489A (it) 1975-08-23
SE426549B (sv) 1983-01-31

Similar Documents

Publication Publication Date Title
JP5192816B2 (ja) 非ゼラチン軟質カプセルシステム
US4088750A (en) Method and preparation for increasing bioavailability of digoxin
US7770361B2 (en) Powder compaction and enrobing
CA1096307A (en) Pharmaceutical preparations
EP0804172B1 (en) Controlled release potassium dosage form
JPS6322032A (ja) ゼラチン封入徐放性組成物及びその製造方法
CA2341024A1 (en) Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
JP2013509403A (ja) 速溶性固体剤形
ZA975827B (en) Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.
CN103099799B (zh) 复合膜状制剂及其制备方法
EP0338383A3 (en) Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
CA2121038C (en) Oral preparation for release in lower digestive tracts
JPS61183220A (ja) 鎮痛性を有する医薬組成物
WO1992004013A1 (en) Multiparticulate sustained release matrix system
CA1063024A (en) Preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoylanthranilic acid and process for their manufacture
CN107441068B (zh) 一种盐酸可乐定口腔膜剂及其制备方法
Patil et al. Development and characterization of chronomodulated drug delivery system of captopril
JPS6136491B2 (it)
Begum et al. A review on manufacturing and evaluation of capsules
AU2013200682B1 (en) Fast Dissolving Solid Dosage Form
EP0358710A1 (en) Improved dry sustained release theophylline oral formulation
JPH10502937A (ja) フシジン酸錠剤の製法
EP0761209A2 (en) Controlled release formulations of ranitidine
EP1331003B1 (en) Extended release formulation containing venlafaxine
GB2175804A (en) Treating cramp

Legal Events

Date Code Title Description
MKEX Expiry